. Biomarker treatment effects in two phase 3 trials of gantenerumab. Alzheimers Dement. 2025 Jan 30;:e14414. Epub 2025 Jan 30 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.